Bioreactor technology in cardiovascular tissue engineering

21Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Cardiovascular tissue engineering is a fast evolving field of biomedical science and technology to manufacture viable blood vessels, heart valves, myocar-dial substitutes and vascularised complex tissues. In consideration of the specific role of the haemodynamics of human circulation, bioreactors are a fundamental of this field. The development of perfusion bioreactor technology is a consequence of successes in extracorporeal circulation techniques, to provide an in vitro environment mimicking in vivo conditions. The bioreactor system should enable an automatic hydrodynamic regime control. Furthermore, the systematic studies regarding the cellular responses to various mechanical and biochemical cues guarantee the viability, bio-monitoring, testing, storage and transportation of the growing tissue. The basic principles of a bioreactor used for cardiovascular tissue engineering are summarised in this chapter. © 2009 Springer.

Cite

CITATION STYLE

APA

Mertsching, H., & Hansmann, J. (2009). Bioreactor technology in cardiovascular tissue engineering. Advances in Biochemical Engineering/Biotechnology. https://doi.org/10.1007/978-3-540-69357-4_2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free